TORL BioTherapeutics logo

TORL BioTherapeutics

Culver City, CA

TORL BioTherapeutics is a clinical-stage biopharmaceutical business focused on creating innovative, antibody-based medicines to improve the lives of cancer patients. They are developing a comprehensive pipeline of innovative preclinical ADCs and mAb in oncologic diseases with high unmet medical needs.

torlbio.com

Company Details

Founded

2018

Employees

Between 5 - 20 employees

Raised

$316,000,000

Headquarters Location

Culver City, CA

Public

No

Acquired

No

CEO

Mark AllesMark Alles

Company Collections

These are collections TORL BioTherapeutics is a part of. Click on the collection name to view similar companies.

TORL BioTherapeutics' Industries